Home » Topics » Regulatory

Regulatory
RSS

FDA approves Cometriq, EMA accepts MAA

Nov. 30, 2012

FDA approves Zilver PTX drug-eluting stent for peripheral arterial disease

Nov. 16, 2012

Bristol-Myers Squibb and AstraZeneca gain European approval for dapagliflozin

Nov. 15, 2012

FDA approves Pfizer's Xeljanz for rheumatoid arthritis

Nov. 8, 2012

Glybera gene therapy approved by the European Commission

Nov. 5, 2012

FDA grants first approval to ocriplasmin

Oct. 18, 2012

FDA approves Abraxane for NSCLC

Oct. 15, 2012

FDA approves Cystaran for corneal cystine crystals

Oct. 5, 2012

Novo Nordisk's insulin degludec obtains first approval

Oct. 2, 2012

Dacogen gains approval in the E.U. for acute myeloid leukemia

Oct. 2, 2012

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...